Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference
March 10 2022 - 08:13AM
Isoray, Inc. (NYSE American: ISR), a medical technology company and
innovator in seed brachytherapy, today announced that Chief
Executive Officer Lori Woods will participate in a virtual fireside
chat at the Oppenheimer 32nd Annual Healthcare Conference on
Thursday, March 17 at 1:20 p.m. ET. CEO Woods and Chief Financial
Officer Jonathan Hunt will also host virtual one-on-one and group
meetings with institutional investors during the conference.
A live webcast of the virtual fireside chat will be available on
Isoray’s Investor Relations section of the Company’s website at
https://isoray.com/investors/presentations/. An on-demand replay
will be available shortly after the conclusion on the Investor
Relations section of the website and will be available for 90
days.
About
IsorayIsoray, Inc. is a
medical technology company pioneering advanced treatment
applications and devices to deliver targeted internal radiation
treatments for cancers throughout the body. Isoray, Inc., through
its subsidiary, Isoray Medical, Inc., is the sole producer of
Cesium-131 brachytherapy seeds. Learn more about this innovative
Richland, Washington company and explore the many benefits and uses
of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter.
Contact
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Feb 2024 to Mar 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2023 to Mar 2024